Efficacy of Individualised Homoeopathic Medicines in Cases of Functional Dyspepsia

To Study the Efficacy of Individualised Homoeopathic Medicines in Cases of Functional Dyspepsia :- A Single Blind, Randomized, Placebo-Controlled Trial - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088131

Enrollment

Registered

2025-06-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K30- Functional dyspepsia

Interventions

Intervention1: Individualised Homoeopathic Medicine: Individualised Homoeopathic Medicine will be Prescribed in Selective Potency as in Required Repetition for 15 Days or as and when it is Required Co

Eligibility

Inclusion criteria

Inclusion criteria: a) Patients covering the diagnostic criteria for FUNCTIONAL DYSPEPSIA (ROME IV CRITERIA) b) Age 20 to 45 years c) Gender both male and female d) All socio- economic status e) Willing to give informed consent

Exclusion criteria

Exclusion criteria: a) Patients having Organic Gastrointestinal diseases. b) Patient having IBS (irritable bowel syndrome). c) Severe psychiatric disorders. d) Patients with malignancies. e) Pregnant and lactating females.

Design outcomes

Primary

Measure	Time frame
1 To See the Role of Individualized Homoeopathic Medicine in comparison with Placebo in Cases of Functional Dyspepsia 2 To Assess the Severity & Outcome of Patients before & after treatment in cases of Functional Dyspepsia by using Short Form-Leeds Dyspepsia Questionnaire (SF-LDQ) 3 To Emerge the Therapeutics of Functional DyspepsiaTimepoint: 3 Months and Interim Analysis at 1.5 Months, if Necessary	—

Measure

Time frame

1 To See the Role of Individualized Homoeopathic Medicine in comparison with Placebo in Cases of Functional Dyspepsia 2 To Assess the Severity & Outcome of Patients before & after treatment in cases of Functional Dyspepsia by using Short Form-Leeds Dyspepsia Questionnaire (SF-LDQ) 3 To Emerge the Therapeutics of Functional DyspepsiaTimepoint: 3 Months and Interim Analysis at 1.5 Months, if Necessary

—

Secondary

Measure	Time frame
1 To Check & Verify the most common age group affected by this condition 2 To Find out the most frequently used MedicinesTimepoint: 3 Months & Interim Analysis at 1.5 Months, if Necessary	—

Countries

India

Contacts

Public ContactDr Devendra Jadav

Jawaharlal Nehru Homoeopathic Medical College

devendra.javad12677@paruluniversity.ac.in9825222758

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026